An optimal strategy for HIV multitherapy

DOI10.1016/J.CAM.2013.12.007MaRDI QIDQ2252419zbMATH OpenOpenAlexFDO

Authors Yinggao Zhou, Yiting Liang, Jianhong Wu

Publication date 17 July 2014

Published in Journal of Computational and Applied Mathematics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1016/j.cam.2013.12.007

zbMATH Keywords

maximum principleoptimal controlgradient methodHIV model

Mathematics Subject Classification ID

Medical applications (general) (92C50) Optimality conditions for problems involving ordinary differential equations (49K15) Numerical methods based on necessary conditions (49M05)

Recommendations

• Optimal treatment strategies for HIV with antibody response
• scientific article; zbMATH DE number 5717094
• Optimal control for HIV-1 multi-drug therapy
• Optimal control for HIV multitherapy enhancement
• Optimal HIV treatment by maximising immune response

Cites work

• scientific article; zbMATH DE number 3167340 (Why is no real title available?)
• scientific article; zbMATH DE number 50791 (Why is no real title available?)
• scientific article; zbMATH DE number 3505708 (Why is no real title available?)
• scientific article; zbMATH DE number 1247361 (Why is no real title available?)
• scientific article; zbMATH DE number 2020917 (Why is no real title available?)
• Differential equations. Classical to controlled
• Dynamics of HIV infection of CD4\(^ +\) T cells
• Mathematical Analysis of HIV-1 Dynamics in Vivo
• Optimal control for HIV multitherapy enhancement
• Optimal control of an HIV immunology model
• Optimal control of the chemotherapy of HIV
• Parameter identifiability and estimation of HIV/AIDS dynamic models

Cited in

(24)

• Short and long period optimization of drug doses in the treatment of AIDS
• Free terminal time optimal control problem of an HIV model based on a conjugate gradient method
• Vector-host epidemic model with direct transmission in random environment
• Optimal control analysis of a tuberculosis model
• Optimal control in a multi-pathways HIV-1 infection model: a comparison between mono-drug and multi-drug therapies
• Effect of awareness programs and travel-blocking operations in the control of HIV/AIDS outbreaks: a multi-domains SIR model
• Fractional optimal control with fish consumption to prevent the risk of coronary heart disease
• Understanding drug resistance for monotherapy treatment of HIV infection
• Optimal controls of the highly active antiretroviral therapy
• Optimal control in epidemiology
• Dynamic multidrug therapies for HIV: Optimal and STI control approaches
• Optimal drug therapy in a multi-pathways HIV-1 infection model with immune response delay
• Optimal control in multi-group coupled within-host and between-host models
• An optimal scheme to boost immunity and suppress viruses for HIV by combining a phased immunotherapy with the sustaining antiviral therapy
• Costs versus benefits: best possible and best practical treatment regimens for HIV
• Optimal treatment strategies for HIV with antibody response
• Optimal control for HIV-1 multi-drug therapy
• Optimal multi-therapeutic HIV treatment using a global optimal switching scheme
• Optimal control for HIV multitherapy enhancement
• Short-term antiretroviral treatment recommendations based on sensitivity analysis of a mathematical model for HIV infection of CD4^+T cells
• Conflict and accord of optimal treatment strategies for HIV infection within and between hosts
• Optimal timing of antiviral therapy in HIV infection
• Optimal therapy regimens for treatment-resistent mutations of HIV
• Short- and long-term optimal control of a mathematical model for HIV infection of \(CD4^{+}T\) cells

This page was built for publication: An optimal strategy for HIV multitherapy

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2252419)